Jiang, Shu-Heng <br/><br/>
Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2.  [electronic resource] 

 -  FASEB journal : official publication of the Federation of American Societies for Experimental Biology  03 2020 
 - 3943-3955 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1530-6860 
<br/><br/><label>Standard No.: </label>10.1096/fj.201901237R  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Glucose--metabolism<br/>Glycolysis--drug effects<br/>Hexokinase--metabolism<br/>Humans<br/>Immunohistochemistry<br/>Lactams--pharmacology<br/>Lactic Acid--metabolism<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Real-Time Polymerase Chain Reaction<br/>Surface Plasmon Resonance